L02-060403-PV1-R1 analysis: /home/Demos/Flow/demo/Peptide Validation

We value your feedback! Please click here to access our 2024 Client Survey.
The survey will remain open until November 1st. Your perspective will help guide our product/service planning and goals for the upcoming year and beyond!

L02-060403-PV1-R1 analysis

Peptide Validation

PROTOCOL Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	LABID Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	ASSAYID Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	Sample Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	ICS blinded Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	SPECIMEN COLLECTION DATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	THAW DATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	ASSAYRUN Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	RELIABLE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	PLATE TEMPLATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	PLATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	Sample order Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	WELL ID Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	COLLECTCT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	SINGLETCT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	LIVECT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	LYMPHCT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	CD3CT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	TCELLSUB Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	NSUB Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	ANTIGEN Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	CYTOKINE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	PFD Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	CYTNUM Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	NREPL Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	METHOD Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	STAIN Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	REPLACE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	Analysis Results Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	FCSFile Name Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN-IL2-TNF+	1	2	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN-IL2+TNF+	2	2	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN+IL2-TNF-	1	5	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN+IL2+TNF-	2	24	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN+IL2+TNF+	3	1	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN-IL2-TNF-	0	31,378	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN-IL2-TNF+	1	0	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN+IL2-TNF-	1	5	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN+IL2+TNF-	2	3	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD4	82,916	Neg Cont	IFN-IL2+TNF-	1	19	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A01	232,350	226,099	207,497	167,995	120,478	CD8	31,386	Neg Cont	IFN-IL2+TNF-	1	0	1	1	S	N	8285	122054.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN-IL2-TNF-	0	86,409	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN-IL2-TNF+	1	2	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN-IL2+TNF+	2	2	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN+IL2-TNF-	1	14	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN+IL2+TNF-	2	20	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN-IL2-TNF-	0	32,132	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN-IL2-TNF+	1	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN+IL2-TNF-	1	3	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN+IL2+TNF-	2	3	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD4	86,471	Neg Cont	IFN-IL2+TNF-	1	24	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-1	ICS025	Blinded	2006-03-30 00:00	Y	Y	A	P1	1	A02	238,108	232,057	213,429	173,909	125,216	CD8	32,138	Neg Cont	IFN-IL2+TNF-	1	0	2	1	S	N	8286	122056.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN-IL2-TNF-	0	66,558	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN-IL2-TNF+	1	1	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN-IL2+TNF+	2	3	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN+IL2-TNF-	1	15	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN+IL2+TNF-	2	19	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN-IL2-TNF-	0	35,907	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN-IL2-TNF+	1	1	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN-IL2+TNF+	2	1	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN+IL2-TNF-	1	4	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN+IL2-TNF+	2	1	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN+IL2+TNF-	2	0	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD4	66,613	Neg Cont	IFN-IL2+TNF-	1	17	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B01	226,139	219,492	198,435	139,322	106,781	CD8	35,915	Neg Cont	IFN-IL2+TNF-	1	1	1	1	S	N	8287	122060.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN-IL2-TNF-	0	66,326	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN-IL2-TNF+	1	3	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN-IL2+TNF+	2	1	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN+IL2-TNF-	1	2	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN+IL2+TNF-	2	24	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN+IL2+TNF+	3	1	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN-IL2-TNF-	0	33,892	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN-IL2-TNF+	1	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN+IL2-TNF-	1	4	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN+IL2+TNF-	2	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD4	66,364	Neg Cont	IFN-IL2+TNF-	1	7	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-2	ICS026	Blinded	2006-03-30 00:00	Y	Y	A	P1	2	B02	226,952	220,701	199,606	135,859	104,410	CD8	33,896	Neg Cont	IFN-IL2+TNF-	1	0	2	1	S	N	8288	122062.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN-IL2-TNF-	0	74,688	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN-IL2-TNF+	1	4	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN+IL2-TNF-	1	9	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN+IL2+TNF-	2	22	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN+IL2+TNF+	3	2	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN-IL2-TNF-	0	46,463	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN-IL2-TNF+	1	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN+IL2-TNF-	1	4	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN+IL2+TNF-	2	4	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD4	74,739	Neg Cont	IFN-IL2+TNF-	1	14	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C01	235,653	228,830	201,000	162,155	124,857	CD8	46,471	Neg Cont	IFN-IL2+TNF-	1	0	1	1	S	N	8289	122066.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN-IL2-TNF-	0	69,750	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN-IL2-TNF+	1	3	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN+IL2-TNF-	1	10	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN+IL2+TNF-	2	16	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN-IL2-TNF-	0	46,880	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN-IL2-TNF+	1	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN+IL2-TNF-	1	5	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN+IL2+TNF-	2	3	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD4	69,795	Neg Cont	IFN-IL2+TNF-	1	16	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-3	ICS027	Blinded	2006-03-30 00:00	Y	Y	A	P1	3	C02	216,523	210,835	186,615	154,515	120,041	CD8	46,890	Neg Cont	IFN-IL2+TNF-	1	2	2	1	S	N	8290	122068.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-4	ICS028	Blinded	2006-03-30 00:00	Y	Y	A	P1	4	D01	250,822	242,632	211,457	156,904	115,695	CD4	86,751	Neg Cont	IFN-IL2-TNF-	0	86,676	1	1	S	N	8291	122072.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-4	ICS028	Blinded	2006-03-30 00:00	Y	Y	A	P1	4	D01	250,822	242,632	211,457	156,904	115,695	CD4	86,751	Neg Cont	IFN-IL2-TNF+	1	9	1	1	S	N	8291	122072.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-4	ICS028	Blinded	2006-03-30 00:00	Y	Y	A	P1	4	D01	250,822	242,632	211,457	156,904	115,695	CD4	86,751	Neg Cont	IFN-IL2+TNF+	2	7	1	1	S	N	8291	122072.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-4	ICS028	Blinded	2006-03-30 00:00	Y	Y	A	P1	4	D01	250,822	242,632	211,457	156,904	115,695	CD4	86,751	Neg Cont	IFN+IL2-TNF-	1	12	1	1	S	N	8291	122072.fcs
PV1	FH	L02-060403-PV1-R1	L02-060403-PV1-R1-4	ICS028	Blinded	2006-03-30 00:00	Y	Y	A	P1	4	D01	250,822	242,632	211,457	156,904	115,695	CD4	86,751	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	8291	122072.fcs

Show Compensation
Experiment Run Graph

LabKey Support

LabKey Support

L02-060403-PV1-R1 analysis